Could Weight Loss Drug Treat Addiction as Well as Obesity? #shorts

Could the class of new weight loss drugs including semaglutide – approved as Ozempic to treat type 2 diabetes and Wegovy to treat obesity – also curb addictions and compulsive behaviors?

As demand for semaglutide for weight loss grew after Wegovy was approved by the FDA in June 2021, personal accounts of unexpected added benefits also began to surface for the class of medications known as GLP-1s, which mimic a natural hormone called glucagon-like peptide-1 that helps a person feel full. #diabetes #weightlossjourney #ozempic #depression #addictionrecovery #addictionrecovery #wegovy #semaglutide #webmd